ArticleMolecules (Basel, Switzerland)2025
Electrochemical Degradation of Venlafaxine on Platinum Electrodes: Identification of Transformation Products by LC-MS/MS and In Silico Ecotoxicity Assessment.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Venlafaxine Removal from Water and Wastewater Using Activated Carbons from Spent Brewery Grains Produced by Conventional vs. Microwave Pyrolysis.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Advanced strategies for the removal of venlafaxine from aqueous environments: a critical review of adsorption and advanced oxidation pathways.RSC advances · 2025Review
- Effective Degradation of Venlafaxine via Biochar Activated Persulfate: Kinetics, Transformation Products, and Toxicity Assessment.Molecules (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antidepressants are emerging contaminants that have raised global concern due to their abuse. Venlafaxine (VFX), a serotonin and norepinephrine reuptake inhibitor, can cause adverse and potentially toxic effects on aquatic organisms. Electrochemical advanced oxidation processes (EAOPs) are gaining attention as promising degradation techniques for a variety of drugs. EAOP methods proposed for VFX degradation mainly utilize boron-doped diamond (BDD) electrodes, characterized by low background current and high oxygen overpotential. However, challenges arise, including delamination from the substrate, difficulties in scaling up, and limited service life. In this study, platinum was employed as an anode for the galvanostatic degradation of VFX, due to its stability and well-established surface cleaning procedure, which ensured high reproducibility. A 0.1 M Na
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.